Skip to main content
logo
Can-Fite BioPharma Ltd. (TLV:CANF)
Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
518.80
+2.80 (0.54%)
Aug 3, 2026, 5:24 PM IDT

Can-Fite BioPharma Ratios and Metrics

Millions ILS. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
2279573269120
Market Cap Growth
-49.15%38.59%77.98%-53.52%-42.86%29.93%
Enterprise Value
-5573923076
Last Close Price
5.1930.0057.0078.00252.00441.00

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-3.943.943.943.9417.82
PS Ratio
17.2260.8423.0911.9024.0645.20
PB Ratio
1.254.412.861.424.362.68
P/TBV Ratio
1.254.412.861.424.362.68

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
-44.2315.920.6510.6328.70

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.010.010.020.010.010.01
Net Debt / Equity Ratio
-1.51-1.51-1.43-1.42-1.77-1.32
Net Debt / EBITDA Ratio
0.850.850.961.090.791.48
Net Debt / FCF Ratio
0.950.951.021.050.731.93
Asset Turnover
0.040.040.070.080.060.06
Quick Ratio
3.133.133.844.423.197.01
Current Ratio
3.463.464.384.913.667.35
Return on Equity (ROE)
-178.24%-178.24%-134.94%-142.49%-107.91%-123.34%
Return on Assets (ROA)
-66.75%-66.75%-53.18%-53.15%-42.73%-53.91%
Return on Capital Employed (ROCE)
-146.70%-146.70%-115.00%-102.80%-148.90%-73.30%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-140.94%-39.89%-50.64%-86.33%-52.20%-32.72%
FCF Yield
-128.36%-36.33%-49.11%-95.47%-55.47%-25.60%
Buyback Yield / Dilution
-126.97%-126.97%-70.22%-56.71%-47.49%-54.32%